Yaz Birth Control Case Sent to Mediator
Less than two weeks before drug manufacturer Bayer was to face a bellwether trial over claims that the company failed to warn women of the increased risk of blood clots associated with its birth-control pills Yaz and Yasmin, the judge overseeing the consolidated cases postponed the hearing and ordered the cases to mediation.
U.S. District Judge David Herndon of Illinois directed attorneys for Bayer and lawyers for women suing the pharmaceutical maker to meet with a mediator to explore the possibility of reaching settlements. Herndon appointed Stephen Saltzburg, a professor at the George Washington University School of Law, to mediate.
To date, more than 10,000 product liability lawsuits have been filed against Bayer over injuries allegedly caused by the oral contraceptives Yaz and Yasmin. After reviewing data on more than 800,000 women who took birth-control pills containing drospirenone—including Yaz and Yasmin—the Food and Drug Administration (FDA) last year issued a warning that women taking oral contraceptives containing drospirenone were more likely to suffer blood clots than women who took birth-control pills without the synthetic hormone.
At least 50 deaths have been linked to birth-control pills containing drospirenone, including Yasmin, Yaz and Ocella, the latter of which is produced by Teva Pharmaceuticals. Complications include an increased risk for blood clots, which can lead to potentially fatal instances of pulmonary embolisms, deep vein thrombosis and stroke.
Despite the increased reports of complications in recent years, Bayer generated more than $1.5 billion in sales in 2010 from its oral contraceptives.
If you suffered complications or a family member died after taking Yasmin or Yaz, please contact PersonalInjury.com for a free case evaluation and to locate an experienced product liability attorney near you.